US5210079A
(en)
*
|
1988-01-07 |
1993-05-11 |
E. I. Du Pont De Nemours And Company |
Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
|
US5315013A
(en)
*
|
1988-01-07 |
1994-05-24 |
E. I. Du Pont De Nemours And Company |
Substituted pyrazole angiotensin II antagonists
|
GB8911854D0
(en)
*
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
CA2020073A1
(en)
*
|
1989-07-03 |
1991-01-04 |
Eric E. Allen |
Substituted quinazolinones as angiotensin ii antagonists
|
EP0409332A3
(en)
*
|
1989-07-19 |
1991-08-07 |
Merck & Co. Inc. |
Substituted triazoles as angiotensin ii antagonists
|
US5411980A
(en)
*
|
1989-07-28 |
1995-05-02 |
Merck & Co., Inc. |
Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
|
EP0412594B1
(en)
*
|
1989-07-28 |
1996-01-03 |
Merck & Co. Inc. |
Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
|
EP0411507B1
(en)
*
|
1989-08-02 |
1994-10-26 |
Takeda Chemical Industries, Ltd. |
Pyrazole derivatives, their production and use
|
NZ234854A
(en)
*
|
1989-08-11 |
1993-02-25 |
Ici Plc |
Quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof
|
IL95975A
(en)
*
|
1989-10-24 |
1997-06-10 |
Takeda Chemical Industries Ltd |
N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
|
US5250554A
(en)
*
|
1989-10-24 |
1993-10-05 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives useful as angiotensin II inhibitors
|
IE903911A1
(en)
*
|
1989-11-20 |
1991-05-22 |
Ici Plc |
Diazine derivatives
|
US5073566A
(en)
*
|
1989-11-30 |
1991-12-17 |
Eli Lilly And Company |
Angiotensin ii antagonist 1,3-imidazoles and use thereas
|
EP0435827A3
(en)
*
|
1989-12-28 |
1991-11-13 |
Ciba-Geigy Ag |
Diaza compounds
|
CA2072363A1
(en)
*
|
1989-12-29 |
1991-06-30 |
Graham J. Moore |
Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
|
ZA9010460B
(en)
*
|
1989-12-29 |
1992-11-25 |
Univ Technologies Int |
Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
|
US5449682A
(en)
*
|
1990-02-13 |
1995-09-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted benzyl element
|
JP2726563B2
(ja)
*
|
1990-02-13 |
1998-03-11 |
メルク・エンド・カムパニー・インコーポレーテツド |
置換ベンジル要素を含むトリアゾールアンギオテンシン▲ii▼拮抗物質
|
CA2036304C
(en)
*
|
1990-02-15 |
2001-04-17 |
Takehiko Naka |
Pyrimidinedione derivatives, their production and use
|
DE122007000050I1
(de)
*
|
1990-02-19 |
2007-11-08 |
Novartis Ag |
Acylverbindungen
|
US5284661A
(en)
*
|
1990-02-22 |
1994-02-08 |
Takeda Chemical Industries, Ltd. |
Fused thiophene derivatives, their production and use
|
CA2036618C
(en)
*
|
1990-02-22 |
2002-10-29 |
Akira Morimoto |
Fused thiophene derivatives, their production and use
|
CA2037630C
(en)
*
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
GB9005354D0
(en)
*
|
1990-03-09 |
1990-05-02 |
Glaxo Group Ltd |
Chemical compounds
|
FR2659655B1
(fr)
*
|
1990-03-19 |
1992-07-24 |
Union Pharma Scient Appl |
Nouveaux derives d'oxypyrazole antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
PT97078B
(pt)
*
|
1990-03-20 |
1997-07-31 |
Sanofi Sa |
Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
|
US5155126A
(en)
*
|
1990-03-20 |
1992-10-13 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
|
FR2659967B1
(fr)
*
|
1990-03-20 |
1992-07-24 |
Sanofi Sa |
Derives d'imidazolinone n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5270317A
(en)
*
|
1990-03-20 |
1993-12-14 |
Elf Sanofi |
N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
|
US5166206A
(en)
*
|
1990-03-30 |
1992-11-24 |
Merck & Co., Inc. |
Substituted pyrimidines, pyrimidinones and pyridopyrimidines
|
DE4010797A1
(de)
*
|
1990-04-04 |
1991-10-10 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
|
US5196444A
(en)
*
|
1990-04-27 |
1993-03-23 |
Takeda Chemical Industries, Ltd. |
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
|
EP0453210A3
(en)
*
|
1990-04-19 |
1993-01-13 |
Imperial Chemical Industries Plc |
Pyridine derivatives
|
US5198439A
(en)
*
|
1990-04-19 |
1993-03-30 |
Imperial Chemical Industries Plc |
Angiotension II antagonizing pyridine derivatives
|
US6004989A
(en)
|
1990-04-27 |
1999-12-21 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
ZA912983B
(en)
|
1990-04-27 |
1992-01-29 |
Takeda Chemical Industries Ltd |
Benzimidazole derivatives,their production and use
|
US5703110A
(en)
*
|
1990-04-27 |
1997-12-30 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
US5098920A
(en)
*
|
1990-05-04 |
1992-03-24 |
G. D. Searle & Co. |
1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
|
US5189051A
(en)
*
|
1990-05-10 |
1993-02-23 |
E. I. Du Pont De Nemours And Company |
Treatment of glaucoma and ocular hypertension with pyrrole angiotensin-II receptor antagonists
|
ES2097208T3
(es)
|
1990-05-11 |
1997-04-01 |
Pfizer |
Composiciones y procedimientos terapeuticos y sinergicos.
|
US5821232A
(en)
*
|
1990-05-11 |
1998-10-13 |
Pfizer Inc. |
Synergistic therapeutic compositions and methods
|
JPH05506443A
(ja)
*
|
1990-05-25 |
1993-09-22 |
ジー.ディー.サール アンド カンパニー |
心臓血管障害の治療用n―置換1,2,4―トリアゾロン化合物
|
CN1034934C
(zh)
*
|
1990-06-19 |
1997-05-21 |
明治制果株式会社 |
血管紧张素ii拮抗性吡啶衍生物的制备方法
|
CA2085584C
(en)
*
|
1990-06-22 |
2003-02-11 |
David John Carini |
Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists
|
US5137902A
(en)
*
|
1990-07-13 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
4-alkylimidazole derivatives and anti-hypertensive use thereof
|
CA2044806A1
(en)
*
|
1990-07-18 |
1992-01-19 |
Roland Jaunin |
Purine derivatives
|
DE4023215A1
(de)
*
|
1990-07-21 |
1992-01-23 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
|
AU8534291A
(en)
*
|
1990-08-10 |
1992-03-02 |
G.D. Searle & Co. |
Renal-selective angiotensin ii antagonists for treatment of hypertension
|
US5217985A
(en)
*
|
1990-08-28 |
1993-06-08 |
G. D. Searle & Co. |
Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
|
US5250548A
(en)
*
|
1990-09-10 |
1993-10-05 |
Abbott Laboratories |
Angiotensin II receptor antagonists
|
IL99372A0
(en)
*
|
1990-09-10 |
1992-08-18 |
Ciba Geigy Ag |
Azacyclic compounds
|
IE912956A1
(en)
*
|
1990-09-10 |
1992-03-11 |
Abbott Lab |
Angiotensin ii receptor antagonists
|
US5140036A
(en)
*
|
1990-09-19 |
1992-08-18 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5229406A
(en)
*
|
1990-09-19 |
1993-07-20 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
AU9024591A
(en)
*
|
1990-10-25 |
1992-05-26 |
G.D. Searle & Co. |
Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
|
AU636066B2
(en)
*
|
1990-10-30 |
1993-04-08 |
Takeda Chemical Industries Ltd. |
Thienoimidazole derivatives, their production and use
|
US5087634A
(en)
*
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
US5238952A
(en)
*
|
1990-10-31 |
1993-08-24 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
DE4036706A1
(de)
*
|
1990-11-17 |
1992-05-21 |
Hoechst Ag |
Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
|
GB9025123D0
(en)
*
|
1990-11-19 |
1991-01-02 |
Ici Plc |
Nitrogen compounds
|
GB9026006D0
(en)
*
|
1990-11-29 |
1991-01-16 |
Glaxo Group Ltd |
Chemical compounds
|
GB9027197D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027198D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
US6025380A
(en)
*
|
1990-12-14 |
2000-02-15 |
Smithkline Beecham Plc |
Medicament
|
GB9027209D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027200D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
US6028091A
(en)
*
|
1990-12-14 |
2000-02-22 |
Smithkline Beecham Plc |
Medicament
|
GB9027201D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027212D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027208D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
US6034114A
(en)
*
|
1990-12-14 |
2000-03-07 |
Smithkline Beecham Plc |
Medicament
|
GB9027211D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027210D0
(en)
*
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
US5175180A
(en)
*
|
1990-12-20 |
1992-12-29 |
G. D. Searle & Co. |
N-substituted n-(alpha-triazolyl-toluyl)pyrrole compounds and use for treatment of circulatory disorders
|
TW197428B
(da)
|
1991-01-04 |
1993-01-01 |
Hoechst Ag |
|
CA2058198A1
(en)
*
|
1991-01-04 |
1992-07-05 |
Adalbert Wagner |
Azole derivatives, process for their preparation, and their use
|
AT395853B
(de)
*
|
1991-01-31 |
1993-03-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
US5153347A
(en)
*
|
1991-01-31 |
1992-10-06 |
E. R. Squibb & Sons, Inc. |
Phosphonate, phosphinate derivatives useful as antihypertensive agents
|
IE920175A1
(en)
*
|
1991-02-11 |
1992-08-12 |
Zeneca Ltd |
Nitrogen heterocycles
|
GB9102803D0
(en)
*
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Pyridine compounds
|
US5472967A
(en)
*
|
1991-02-20 |
1995-12-05 |
Synthelabo |
4-pyrimidinone derivatives their preparation and their application in therapy
|
IE920540A1
(en)
*
|
1991-02-21 |
1992-08-26 |
Sankyo Co |
1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
|
US5616599A
(en)
*
|
1991-02-21 |
1997-04-01 |
Sankyo Company, Limited |
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
|
US5187271A
(en)
*
|
1991-02-28 |
1993-02-16 |
G. D. Searle & Co. |
N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
|
US6008368A
(en)
*
|
1993-04-28 |
1999-12-28 |
G. D. Searle & Co. |
Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists
|
US5236928A
(en)
*
|
1991-03-19 |
1993-08-17 |
Merck & Co., Inc. |
Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists
|
US5191086A
(en)
*
|
1991-03-19 |
1993-03-02 |
E.R. Squibb & Sons, Inc. |
Imidazole and benzimidazole derivatives
|
US5196537A
(en)
*
|
1991-03-21 |
1993-03-23 |
G. D. Searle & Co. |
5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5187179A
(en)
*
|
1991-03-22 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
|
US5128327A
(en)
*
|
1991-03-25 |
1992-07-07 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
|
US5177074A
(en)
*
|
1991-03-26 |
1993-01-05 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
US5164403A
(en)
*
|
1991-04-05 |
1992-11-17 |
G. D. Searle & Co. |
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
|
US5157040A
(en)
*
|
1991-04-05 |
1992-10-20 |
Merck & Co., Inc. |
Substituted quinolines as angiotensin ii antagonists
|
US5155117A
(en)
*
|
1991-04-12 |
1992-10-13 |
G. D. Searle & Co. |
1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
|
TW274551B
(da)
*
|
1991-04-16 |
1996-04-21 |
Takeda Pharm Industry Co Ltd |
|
US5190942A
(en)
*
|
1991-04-22 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
|
US5252574A
(en)
*
|
1991-04-26 |
1993-10-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted thiophene or furan
|
WO1992020662A1
(en)
*
|
1991-05-10 |
1992-11-26 |
Merck & Co., Inc. |
Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
|
US5198438A
(en)
*
|
1991-05-07 |
1993-03-30 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
US5436259A
(en)
*
|
1991-05-10 |
1995-07-25 |
Merck & Co., Inc. |
Substituted 1,2,4-triazolin-3-one compounds bearing acidic functional groups as balanced angiotensin II antagonists
|
NZ242724A
(en)
*
|
1991-05-15 |
1994-09-27 |
Du Pont |
Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
|
US5175164A
(en)
*
|
1991-06-05 |
1992-12-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
|
IL102183A
(en)
*
|
1991-06-27 |
1999-11-30 |
Takeda Chemical Industries Ltd |
The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
|
US5177097A
(en)
*
|
1991-07-24 |
1993-01-05 |
E. R. Squibb & Sons, Inc. |
Acyl amidine and acyl, guanidine substituted biphenyl derivatives
|
US5246944A
(en)
*
|
1991-08-13 |
1993-09-21 |
Merck & Co., Inc. |
Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
|
AP254A
(en)
*
|
1991-09-05 |
1993-05-05 |
Glaxo Group Ltd |
C-Linked pyrazole derivatives.
|
US5149699A
(en)
*
|
1991-10-24 |
1992-09-22 |
American Home Products Corporation |
Substituted pyridopyrimidines useful as antgiotensin II antagonists
|
US5256654A
(en)
*
|
1991-10-24 |
1993-10-26 |
American Home Products Corporation |
Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
|
US5484937A
(en)
*
|
1992-08-04 |
1996-01-16 |
G.D. Searle & Co. |
N-substituted N-(α-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders
|
US5322950A
(en)
*
|
1991-12-05 |
1994-06-21 |
Warner-Lambert Company |
Imidazole with angiotensin II antagonist properties
|
US5389661A
(en)
*
|
1991-12-05 |
1995-02-14 |
Warner-Lambert Company |
Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
|
US5212177A
(en)
*
|
1991-12-16 |
1993-05-18 |
E. R. Squibb & Sons, Inc. |
Indole and benzimidazole-substituted dihydropyrimidine derivatives
|
US5350752A
(en)
*
|
1991-12-16 |
1994-09-27 |
E. R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
US5234923A
(en)
*
|
1991-12-16 |
1993-08-10 |
E. R. Squibb & Sons, Inc. |
Substitute indole and benzimidazole derivatives
|
GB2263635A
(en)
*
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substitiuted triazoles as neurotensin antagonists
|
US5240953A
(en)
*
|
1992-01-30 |
1993-08-31 |
Ortho Pharmaceutical Corporation |
Substituted triazoles as angiotensin ii inhibitors
|
US5326776A
(en)
*
|
1992-03-02 |
1994-07-05 |
Abbott Laboratories |
Angiotensin II receptor antagonists
|
TW215434B
(da)
*
|
1992-03-07 |
1993-11-01 |
Hoechst Ag |
|
US5208234A
(en)
*
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Substituted imidazole phosphonic and phosphinic acid derivatives
|
US5616591A
(en)
*
|
1992-03-27 |
1997-04-01 |
E.R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted quinoline derivatives
|
US5294722A
(en)
*
|
1992-04-16 |
1994-03-15 |
E. R. Squibb & Sons, Inc. |
Process for the preparation of imidazoles useful in angiotensin II antagonism
|
US5212195A
(en)
*
|
1992-05-13 |
1993-05-18 |
Syntex (U.S.A.) Inc. |
Substituted indole antagonists derivatives which are angiotensin II
|
US5401851A
(en)
*
|
1992-06-03 |
1995-03-28 |
Eli Lilly And Company |
Angiotensin II antagonists
|
JP3501484B2
(ja)
*
|
1992-12-17 |
2004-03-02 |
三共株式会社 |
ビフェニル誘導体
|
US5451597A
(en)
*
|
1993-05-27 |
1995-09-19 |
G.D. Searle & Co. |
Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists
|
EP0628559B1
(en)
*
|
1993-06-10 |
2002-04-03 |
Beiersdorf-Lilly GmbH |
Pyrimidine compounds and their use as pharmaceuticals
|
US5571813A
(en)
*
|
1993-06-10 |
1996-11-05 |
Beiersdorf-Lilly Gmbh |
Fused pyrimidine compounds and their use as pharmaceuticals
|
US5412102A
(en)
*
|
1994-05-27 |
1995-05-02 |
Syntex (U.S.A.) Inc. |
Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
|
US5527920A
(en)
*
|
1994-11-18 |
1996-06-18 |
Singh; Inder P. |
Economical manufacturing process for 1,2,3-triazoles
|
FR2742148B1
(fr)
*
|
1995-12-08 |
1999-10-22 |
Sanofi Sa |
Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
|
AU751139B2
(en)
*
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
AU2745199A
(en)
|
1998-03-04 |
1999-09-20 |
Takeda Chemical Industries Ltd. |
Sustained-release preparation for aii antagonist, production and use thereof
|
IL145508A0
(en)
*
|
1999-03-26 |
2002-06-30 |
Euro Celtique Sa |
Aryl substituted pyrazole, imidazole, oxazole, thiazole and pyrrole derivatives and pharmaceutical compositions containing the same
|
SE9903028D0
(sv)
|
1999-08-27 |
1999-08-27 |
Astra Ab |
New use
|
CN1321112C
(zh)
|
2000-03-24 |
2007-06-13 |
欧洲凯尔特股份有限公司 |
作为钠通道阻滞剂的芳基取代的吡唑、三唑和四唑化合物
|
US7812044B2
(en)
|
2001-11-13 |
2010-10-12 |
Takeda Pharmaceutical Company Limited |
Anticancer agents
|
DE10335027A1
(de)
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
DE10306179A1
(de)
|
2003-02-13 |
2004-08-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
|
ITTO20040264A1
(it)
*
|
2004-04-28 |
2004-07-28 |
Rotta Res Lab Spa |
Nuovi derivati pirrolici ad attivita' angiotensina-ii antagonista
|
JP5072965B2
(ja)
|
2006-08-03 |
2012-11-14 |
ロッタファルム・ソシエタ・ペル・アチオニ |
高選択性および経口有効性cox−2インヒビターである3−置換−1,5−ジアリール−2−アルキルピロール
|
EP1908469A1
(en)
|
2006-10-06 |
2008-04-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
DK2170930T3
(da)
|
2007-06-04 |
2012-11-05 |
Synergy Pharmaceuticals Inc |
Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
KR102272746B1
(ko)
|
2013-06-05 |
2021-07-08 |
보슈 헬스 아일랜드 리미티드 |
구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
|
CA3067918A1
(en)
|
2017-07-07 |
2019-01-10 |
Boehringer Ingelheim Vetmedica Gmbh |
Angiotensin ii receptor antagonish for the prevention or treatment of hypertension in cats
|
CN114163391B
(zh)
*
|
2021-12-14 |
2024-02-02 |
迪嘉药业集团股份有限公司 |
一种坎地沙坦中间体及坎地沙坦的制备方法
|